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TO THE EDITOR
It was with utmost interest that we
read the recent publication by Zhang
et al. (2006) in the August 2006 online
issue of the Journal of Investigative
Dermatology. The paper describes di-
rect DNA sequencing and microsatel-
lite analysis using 10 polymorphic
markers to study loss of heterozygosity
(LOH) in six randomly selected patients
from two Chinese families suffering
from disseminated superficial actinic
porokeratosis (DSAP) (Zhang et al.,
2006). These LOH studies are largely
based on their previous linkage data
and the results of mutation analysis in
two out of three Chinese families
affected with DSAP. Zhang and co-
workers concluded there that sequence
variants in the slingshot (SSH1) gene
(Zhang et al., 2004) as well as the
promoter region of the actin-related
protein2/3 complex, subunit 3 (ARPC3)
gene (Zhang et al., 2005) are associated
with this autosomal dominantly inher-
ited disorder.
We have considerable reservations
as to the validity and interpretation of
the data presented by the authors. This
is mainly owing to: (i) our unsuccessful
attempts to repeat and confirm a large
body of experiments previously carried
out by Zhang and co-workers (unpub-
lished data), (ii) the fact that to the best
of our knowledge no other group has
reported on SSH1 gene mutations in
DSAP to date and, most importantly,
(iii) contradictory data when comparing
results published by the authors in the
past (Zhang et al., 2004; Zhang et al.,
2005) with the very same molecular
genetic data shown in this publication
(Zhang et al., 2006).
To date, three different chromoso-
mal loci have been implicated in the
etiopathogenesis of DSAP in the Chi-
nese population, 15q25.1–q26.1 (Xia
et al., 2002), 18p11.3 (Wei et al.,
2004), and 12q23.2–q24.1 (Zhang
et al., 2004). The latter chromosomal
region harbors several genes, of which
some were studied for disease-causing
mutations by the authors in the past
(Zhang et al., 2004, 2005a, b, c).
Although they first reported about a
causative mutation in SSH1 (Zhang
et al., 2004), they later on claimed that
sequence deviations in at least two
other genes within the candidate inter-
val, ARPC3 (Zhang et al., 2005a) and
SART3 (Zhang et al., 2005b), would
also be associated with DSAP. We find
it unlikely that mutations in three
different genes that are not in the same
molecular pathway, even if located in
close genomic vicinity, would all con-
fer exactly the same disease phenotype.
We are currently caring for five un-
related Dutch patients and families
diagnosed in the Maastricht University
Centre for Molecular Dermatology.
Although a search for mutations in
ARPC3 and SART3 has not yet been
completed we have studied these five
patients for sequence deviations in
SSH1 without detecting any pathogenic
mutation. Although the results of our
own efforts to reproduce some of the
data previously published by Zhang
and co-workers are somewhat surpris-
ing, they might still be explained by the
apparent locus heterogeneity encoun-
tered in DSAP, with candidate loci
encountered on three different chromo-
somes even within the Chinese popula-
tion. Thus, it is conceivable that other
as yet unknown genes could be asso-
ciated with the disease in our Dutch
Caucasian patients and those of other
ethnic origins. Still, we wonder why
other research groups have not detected
further SSH1 mutations in their families
with DSAP since the first report by
Zhang and co-workers.
More interestingly, the authors them-
selves contribute to the doubts that arise
with regard to the validity of their data
(Zhang et al., 2006). In 2004, they
reported the discovery of a sequence
variation, S63N, in the SSH1 gene,
which they claim to be causative in at
least one Chinese family with DSAP
(Zhang et al., 2004). This putative
missense mutation consists of a G-A
transition (AGT to AAT) at amino-acid
position 63 of the encoded protein.
Although the authors now studied five
individuals from the same family carry-
ing deviation S63N for LOH in the
present study, they present surprising
and contradictory data in their electro-
pherogram in Figure 1a (Zhang et al.,
2006). In the top panel they show the
wild-type sequence with a black G
peak at nucleotide two of codon 63 in
an unaffected control individual. In the
bottom panel they demonstrate what
they refer to as LOH, reflected by a high
green A peak and some negligible
amount of wild-type G signal encoun-
tered in a porokeratotic lesion of a
member of family 2 (Zhang et al.,
2006). Consequently, one would ex-
pect to see a heterozygous G/A peak in
the middle panel, reflecting the muta-
tion status in clinically unaffected skin
(and blood) of these patients. To our
surprise, however, we do not see the
expected heterozygous nucleotide
change but rather a clear heterozygous
C/A peak (Zhang et al., 2006). Hence,
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this would not reflect a substitution of
serine by asparagine but rather a
change to a threonine residue (ACT).
We think that the data presented by
Zhang and co-workers allow for either
of the following conclusions: Either
nucleotide position two at codon 63
in SSH1 is (highly) polymorphic and,
therefore, S63N reflects an innocuous
polymorphism rather than a true muta-
tion. Or the authors erroneously show a
different part of this patient’s genome,
but not the relevant heterozygous DNA
sections necessary to support their
previous notion that S63N is indeed
causative in DSAP and their current
assumption that these data indicate
somatic LOH in this patient suffering
from DSAP. Further we cannot see the
relevance of performing LOH studies in
DSAP by looking for the promotor
transition c.804G-A in ARPC3, con-
sidering that the authors themselves
state in a previous publication that this
nucleotide change was not only ob-
served in affected individuals from
family 2 but also in healthy control
individuals (Zhang et al., 2005a), thus
indicating that it is a common poly-
morphism rather than a mutation caus-
ing DSAP.
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TO THE EDITOR
To our knowledge, few groups focus on
the study of disseminated superficial
actinic porokeratosis (DSAP) etiopatho-
genesis, and they have not reported the
candidate genes of DSAP. Our results
confirmed the research of other groups,
and we also found variations of the SSH1,
ARPC3, and SART3 genes. Because we
have found no reports about the gene
causing DSAP, we published our findings
hoping to learn other researcher’s re-
sponses. Although Frank et al. (2007)
raised strong doubts about our results, we
are glad to discuss our study.
We never confirmed in our papers
that SSH1, ARPC3, or SART3 are the
genes causing DSAP; at this time, we
have reported three candidate genes for
DSAP. Like Frank et al. we are puzzled
why no other researchers have reported
on the disease gene, whether it is SSH1
or not.
In our papers, we suggest that SSH1,
ARPC3, or SART3 are candidate genes,
not the genes causing DSAP. In
12q23.2–24.1, there may be only one
gene causing DSAP, but that does not
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Figure 1. Chromatograms of the normal and
mutated sequences and LOH in two affected
members in Family 2. (a) NM_018984.2:
c.188G4A (p.Ser63Asn) at SSH1.
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